TRPA1 and rheumatoid arthritis: Past studies have reported that, in RA, CBD activates TRPA1 and mitochondrial targets, which reduces the production of IL-6 and MMP-3 in synovial fibroblasts to exert anti-inflammatory effects (Lowin et al., 2020).